433 related articles for article (PubMed ID: 25594496)
1. Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis.
Treichl B; Bachler M; Lorenz I; Friesenecker B; Oswald E; Schlimp CJ; Pedross F; Fries D
Semin Thromb Hemost; 2015 Feb; 41(1):61-7. PubMed ID: 25594496
[TBL] [Abstract][Full Text] [Related]
2. Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
Keegan SP; Gallagher EM; Ernst NE; Young EJ; Mueller EW
Ann Pharmacother; 2009 Jan; 43(1):19-27. PubMed ID: 19116377
[TBL] [Abstract][Full Text] [Related]
3. Argatroban anticoagulation in critically ill patients.
Beiderlinden M; Treschan TA; Görlinger K; Peters J
Ann Pharmacother; 2007 May; 41(5):749-54. PubMed ID: 17440009
[TBL] [Abstract][Full Text] [Related]
4. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
5. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
Levine RL; Hursting MJ; McCollum D
Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
[TBL] [Abstract][Full Text] [Related]
6. Use of argatroban: experiences in continuous renal replacement therapy in critically ill patients after cardiac surgery.
Klingele M; Bomberg H; Lerner-Gräber A; Fliser D; Poppleton A; Schäfers HJ; Groesdonk HV
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1918-24. PubMed ID: 24485959
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
Vo QA; Lin JK; Tong LM
Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
[TBL] [Abstract][Full Text] [Related]
8. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Guzzi LM; McCollum DA; Hursting MJ
J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.
Mayerhöfer T; Joannidis M; Peer A; Perschinka F; Fries D; Mair P; Gasteiger L; Bachler M; Kilo J; Herkner H; Schwameis M; Schellongowski P; Nagler B; Kornfehl A; Staudinger T; Buchtele N
Thromb Res; 2024 Apr; 236():161-166. PubMed ID: 38452448
[TBL] [Abstract][Full Text] [Related]
10. Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
Kim SC; Tran N; Schewe JC; Boehm O; Wittmann M; Graeff I; Hoeft A; Baumgarten G
J Cardiothorac Surg; 2015 Feb; 10():19. PubMed ID: 25879883
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
Beiderlinden M; Werner P; Bahlmann A; Kemper J; Brezina T; Schäfer M; Görlinger K; Seidel H; Kienbaum P; Treschan TA
BMC Anesthesiol; 2018 Feb; 18(1):18. PubMed ID: 29426286
[TBL] [Abstract][Full Text] [Related]
12. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
[TBL] [Abstract][Full Text] [Related]
13. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
Ansara AJ; Arif S; Warhurst RD
Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
[TBL] [Abstract][Full Text] [Related]
14. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra
Bachler M; Hell T; Bösch J; Treml B; Schenk B; Treichl B; Friesenecker B; Lorenz I; Stengg D; Hruby S; Wallner B; Oswald E; Ströhle M; Niederwanger C; Irsara C; Fries D
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32244368
[TBL] [Abstract][Full Text] [Related]
16. Argatroban therapy in women with heparin-induced thrombocytopenia.
Jang IK; Baron SJ; Hursting MJ; Anglade E
J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
[TBL] [Abstract][Full Text] [Related]
17. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
18. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
19. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
